ASCTN-TRAINING

ASCTN-Training is addressing existing gaps within Human Stem Cell-based Neuronal disorders (NDs) Modelling (NDM) for research to develop new medicines for the treatment of neurological disorders such as Parkinson's (PD), Huntington's (HD) and Demyelination's diseases. These highly-prevalent conditions occur as a result of acute or progressive loss of cells, glial or neuronal, and structures and function in the brain and are associated with short- and long-term impairments and disabilities with high emotional, financial and social burden to the patients, their families and their friends... ASCTN-Training is a four-year project, funded by the European Union Horizon 2020 Programme (H2020-MSCA-ITN-2018) under the Marie Skłodowska-Curie Initial Training Network and Grant Agreement No. 813851. ASCTN-Training is addressing existing gaps within Human Stem Cell-based Neuronal disorders (NDs) Modelling (NDM) for research to develop new medicines for the treatment of neurological disorders (e.g...